/* Via Victoria: hard lock to the intended light colour palette on mobile browsers. */
Leukaemia, explained simply / Episode 08

Blinatumomab

A short illustrated guide from our family experience. Swipe sideways on your phone to see all six slides.

English overview

Blinatumomab is a bispecific antibody therapy that helps bring T cells close to CD19-positive B cells. It is used in selected forms of B-cell acute lymphoblastic leukaemia under specialist care.

The six illustrated slides below retain their original Slovak text. This English overview is informational and is not a substitute for medical advice. Individual diagnosis and treatment decisions must be made by a qualified medical team.

1 / 6
Blinatumomab — slide 1 of 6, original Slovak text
Blinatumomab — slide 2 of 6, original Slovak text
Blinatumomab — slide 3 of 6, original Slovak text
Blinatumomab — slide 4 of 6, original Slovak text
Blinatumomab — slide 5 of 6, original Slovak text
Blinatumomab — slide 6 of 6, original Slovak text
← 07 / Interfant-21